Colorectal Cancer Clinical Trial
Official title:
Colorectal Cancer (CRC) Screening in First-Degree Relatives (FDRs) of Hispanic CRC Patients
Primary Objectives:
1. To evaluate knowledge, beliefs, attitudes and values that influence perceptions and
utilization of colorectal cancer screening (CRCS) among first-degree relatives of
Hispanic CRC patients.
2. To assess factors influencing Hispanic CRC patients' communication of CRC risk and
screening information to their FDRs.
Secondary Objective:
1) To establish the feasibility of recruiting Hispanic CRC patients and their FDRs from the
institutional patient database and/or MDACC clinics.
CRC PATIENTS AND THEIR FDRS:
You will be asked to complete a questionnaire by telephone interview. The study researcher
who calls you will ask for your permission to audiotape the interview. The questionnaire
asks about your awareness of screening tests for colorectal cancer, your family's past use
of these screening tests, your attitudes toward colorectal cancer screening, and how you
discuss colorectal cancer risk and screening with your family and health care providers.
Some demographic information also will be collected (such as your age or marital status).
The questionnaire will take between 30 and 45 minutes to complete.
Your answers to the questions and your personal information will be kept strictly
confidential. Your questionnaire answers will be identified with a code number, rather than
a name, so that you cannot be identified. Audiotaped recordings will be destroyed after all
the data have been collected and studied (no longer than 5 years).
This is an investigational study. Up to 60 colorectal cancer patients and their close
relatives may be enrolled in the study. All will be enrolled at M. D. Anderson.
KEY INFORMANT:
You will be asked to complete a psychosocial interview either in person or by telephone. The
study staff member interviewing you will ask you for permission to audiotape the interview.
You will be asked to review the interview guides for colorectal cancer patients and their
first degree relatives (FDRs), and provide feedback about them. The interviewer will ask for
your opinions about Hispanics' awareness and understanding of colorectal cancer screening.
You will also be asked for your opinion about cultural beliefs and practices that may
influence participation in colorectal cancer screening. The interview will take between 30
and 45 minutes to complete.
Your answers to the questions and your personal information will be kept strictly
confidential. Your questionnaire answers will be identified with a code number, rather than
a name, so that you cannot be identified. Audiotaped recordings will be destroyed after all
the data have been collected and studied (no longer than 5 years).
This is an investigational study. Up to 15 key informants may be enrolled in this study. All
will be enrolled at M. D. Anderson.
;
Observational Model: Case-Only, Time Perspective: Prospective
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05400122 -
Natural Killer (NK) Cells in Combination With Interleukin-2 (IL-2) and Transforming Growth Factor Beta (TGFbeta) Receptor I Inhibitor Vactosertib in Cancer
|
Phase 1 | |
| Active, not recruiting |
NCT05551052 -
CRC Detection Reliable Assessment With Blood
|
||
| Completed |
NCT00098787 -
Bevacizumab and Oxaliplatin Combined With Irinotecan or Leucovorin and Fluorouracil in Treating Patients With Metastatic or Recurrent Colorectal Cancer
|
Phase 2 | |
| Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
| Recruiting |
NCT05425940 -
Study of XL092 + Atezolizumab vs Regorafenib in Subjects With Metastatic Colorectal Cancer
|
Phase 3 | |
| Suspended |
NCT04595604 -
Long Term Effect of Trimodal Prehabilitation Compared to ERAS in Colorectal Cancer Surgery.
|
N/A | |
| Completed |
NCT03414125 -
Effect of Mailed Invites of Choice of Colonoscopy or FIT vs. Mailed FIT Alone on Colorectal Cancer Screening
|
N/A | |
| Completed |
NCT02963831 -
A Study to Investigate ONCOS-102 in Combination With Durvalumab in Subjects With Advanced Peritoneal Malignancies
|
Phase 1/Phase 2 | |
| Recruiting |
NCT05489211 -
Study of Dato-Dxd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
|
Phase 2 | |
| Terminated |
NCT01847599 -
Educational Intervention to Adherence of Patients Treated by Capecitabine +/- Lapatinib
|
N/A | |
| Completed |
NCT05799976 -
Text Message-Based Nudges Prior to Primary Care Visits to Increase Care Gap Closure
|
N/A | |
| Recruiting |
NCT03874026 -
Study of Folfiri/Cetuximab in FcGammaRIIIa V/V Stage IV Colorectal Cancer Patients
|
Phase 2 | |
| Active, not recruiting |
NCT03170960 -
Study of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors
|
Phase 1/Phase 2 | |
| Completed |
NCT03167125 -
Participatory Research to Advance Colon Cancer Prevention
|
N/A | |
| Completed |
NCT03181334 -
The C-SPAN Coalition: Colorectal Cancer Screening and Patient Navigation
|
N/A | |
| Recruiting |
NCT04258137 -
Circulating DNA to Improve Outcome of Oncology PatiEnt. A Randomized Study
|
N/A | |
| Recruiting |
NCT05568420 -
A Study of the Possible Effects of Medication on Young Onset Colorectal Cancer (YOCRC)
|
||
| Recruiting |
NCT02972541 -
Neoadjuvant Chemotherapy Verse Surgery Alone After Stent Placement for Obstructive Colonic Cancer
|
N/A | |
| Completed |
NCT02876224 -
Study of Cobimetinib in Combination With Atezolizumab and Bevacizumab in Participants With Gastrointestinal and Other Tumors
|
Phase 1 | |
| Completed |
NCT01943500 -
Collection of Blood Specimens for Circulating Tumor Cell Analysis
|
N/A |